Daniel McGahn
Chief Executive Officer bei AMERICAN SUPERCONDUCTOR CORPORATION
Vermögen: 15 Mio $ am 31.03.2024
Profil
Daniel Patrick McGahn is currently the Chairman, President & Chief Executive Officer at American Superconductor Corp.
He previously served as a Director at BioDE Ventures Ltd.
and as an Independent Director at Exro Technologies, Inc. from 2017 to 2021.
McGahn also held the position of Chief Marketing Officer & Executive Vice President at Konarka Technologies, Inc. from 2003 to 2006.
Additionally, he served as the Chief Operating Officer & General Manager at Hyperion Catalysis International, Inc. McGahn obtained his undergraduate and graduate degrees from the Massachusetts Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.06.2023 | 1 088 672 ( 3,01% ) | 15 Mio $ | 31.03.2024 |
Aktive Positionen von Daniel McGahn
| Unternehmen | Position | Beginn |
|---|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Chief Executive Officer | 16.06.2011 |
Ehemalige bekannte Positionen von Daniel McGahn
| Unternehmen | Position | Ende |
|---|---|---|
| EXRO TECHNOLOGIES INC. | Director/Board Member | 19.08.2021 |
Konarka Technologies, Inc.
 Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Sales & Marketing | 01.01.2006 |
BioDE Ventures Ltd.
 BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Director/Board Member | - |
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Chief Operating Officer | - |
Ausbildung von Daniel McGahn
| Massachusetts Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Producer Manufacturing |
| EXRO TECHNOLOGIES INC. | Producer Manufacturing |
| Private Unternehmen | 3 |
|---|---|
Konarka Technologies, Inc.
Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Electronic Technology |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Producer Manufacturing |
BioDE Ventures Ltd.
BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Health Technology |
